Patient Guide: Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 9 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04553770
Status: 🟢 Enrolling Now
Condition: Breast Neoplasms
Phase: PHASE2

Where You Can Participate

This study is available at 9 locations across the country.

Top locations include:
  • • Fullerton, California
  • • Los Alamitos, California
  • • Los Angeles, California
  • • And 6 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer - Join Clinical Trial NCTNCT04553770

How to Join This Clinical Trial - NCTNCT04553770

Learn how to participate in this PHASE2 trial studying an investigational therapy for Breast Neoplasms. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Breast Neoplasms. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Breast Neoplasms
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT04553770 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 9 locations. Find a study site near you:

Clinical Research Site

Fullerton, California 92835 - United States

Status: RECRUITING

Clinical Research Site

Los Alamitos, California 90720 - United States

Status: RECRUITING

Clinical Research Site

Los Angeles, California 90095 - United States

Status: RECRUITING

Clinical Research Site

Torrance, California 90602 - United States

Status: RECRUITING

Clinical Research Site

Whittier, California 90602 - United States

Status: RECRUITING

Clinical Research Site

Orlando, Florida 32806 - United States

Status: WITHDRAWN

Clinical Research Site

Fort Wayne, Indiana 46804 - United States

Status: WITHDRAWN

Clinical Research Site

Wichita, Kansas 67214 - United States

Status: RECRUITING

Clinical Research Site

Boston, Massachusetts 02114 - United States

Status: RECRUITING

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Breast Neoplasms:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships